Testing effectiveness (Phase 2)Study completedNCT02607553
What this trial is testing
Safety and Activity of G-202 in Patients With Clear Cell Renal Cell Carcinoma That Expresses PSMA
Who this might be right for
Clear Cell Renal Cell Carcinoma
GenSpera, Inc. 2